Member News
-
Valeo Pharma Announces DTC Eligibility for the Trading of Its Shares on the US OTCQB Market
December 29, 2020 (Source) — Valeo Pharma Inc. (CSE: VPH) (OTCQB: VPHIF) (FSE: VP2) (“Valeo”), a Canadian pharmaceutical…
-
Valeo Pharma Announces Health Canada Approval for Redesca™ and Redesca Hp™
December 9, 2020 (Source) — Commercial launch to impact first half 2021 revenue $30 million forecasted annual peak sales…
-
Valeo Pharma announces Amikacin approval in CANADA and U.S. launch of Ethacrynate Sodium
November 12, 2020 (Source) — Amikacin receives Health Canada approval, commercialization to start in first half of 2021…
-
Valeo Pharma Announces That Hesperco(TM) Has Started Shipping
October 13, 2020 (Source) — Hesperco TM capsules online orders now shipping Hesperco TM capsules retailer sales to begin early November Valeo…
-
Valeo Pharma Reports its Third Quarter 2020 Results and Highlights
September 29, 2020 (Source) — $6.9 million bought deal offering with full exercice of over-allotment option $1.7 million…
